MDxHealth SA
MDXH
$2.04
$0.073.55%
NASDAQ
| 12/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -30.51% | 36.18% | -11.39% | -8.49% | 27.31% |
| Total Depreciation and Amortization | 11.31% | 77.00% | 15.17% | 1.24% | 16.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 30.86% | -31.40% | -1.35% | 67.89% | -47.69% |
| Change in Net Operating Assets | 248.62% | 42.06% | -32.08% | 63.54% | -153.15% |
| Cash from Operations | 112.12% | 57.72% | -31.84% | 23.51% | -29.22% |
| Capital Expenditure | 71.88% | 44.83% | 14.63% | 58.57% | 72.05% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -3,441.98% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4,051.54% | 257.93% | 202.07% | -0.96% | 11.75% |
| Cash from Investing | 882.97% | 66.12% | 97.04% | 50.70% | 50.08% |
| Total Debt Issued | 100.00% | -- | -- | -- | -- |
| Total Debt Repaid | -784.71% | 92.67% | -8.24% | -7,444.66% | -25.49% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -74.37% | -122.57% | -83.63% | -111.50% | -34.42% |
| Cash from Financing | -682.92% | 138.55% | 1,581.41% | 934.17% | -104.58% |
| Foreign Exchange rate Adjustments | 100.00% | -222.22% | -97.12% | 95.72% | 80.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -20.53% | 76.06% | 513.26% | 178.00% | -124.08% |